Recombinant Candida boidinii Peroxisomal membrane protein PMP30B (PEX11B)

What is PMP30B and how is it related to the PEX11 family?

PMP30B is a peroxisomal membrane protein from the yeast Candida boidinii that functions as a homolog of the PEX11 family of proteins. PEX11 proteins are integral peroxisomal membrane proteins (PMPs) that play a direct role in peroxisome division . The human PEX11 gene was initially identified through expressed sequence tag homology search using the Candida boidinii PEX11 as a template, followed by screening of a human liver cDNA library . The human PEX11 encodes Pex11p, a protein comprising 247 amino acids with two transmembrane segments and a dilysine motif at the C-terminus . In mammals, there are two forms of PEX11 (alpha and beta), both of which are integral peroxisomal membrane proteins with roles in peroxisome proliferation .

What is the structure and topology of PMP30B/PEX11B proteins?

The PEX11B protein structure features critical elements that determine its function and localization. In humans, the PEX11 protein (Pex11p) contains 247 amino acids with two transmembrane segments and an important dilysine motif at the C-terminus . Both the N-terminal and C-terminal portions of the protein are exposed to the cytosol, suggesting a hairpin-like insertion into the peroxisomal membrane . The sequence analysis of PMP30B from Candida boidinii reveals high conservation between different variants, with PMP30A and PMP30B sharing 93% identity in their coding regions, suggesting they likely perform the same function in this organism . The amino acid sequences of the variants differ in only a few codons, and both the 5' and 3' untranslated regions are highly conserved as well .

How do PEX11 proteins relate to peroxisome division and proliferation?

PEX11 proteins directly induce peroxisome division through a mechanism independent of peroxisomal metabolic functions. Experimental evidence demonstrates that overexpression of PEX11B in human fibroblasts causes a significant increase in peroxisome number over time, occurring in three kinetic steps: normal appearance at initial time point (1.5-2 hours), elongation at the second time point (4-8 hours), and greatly increased number by the third time point (24-48 hours) . This proliferative effect occurs even in cells lacking peroxisomal metabolic functions, as demonstrated in the homozygous human mutant cell line PBD005, where cells transfected with PEX11Bmyc showed thirty times higher peroxisome abundance than control cells . Similar results were observed in yeast experiments where peroxisome number increased when PEX11 was expressed, even in the absence of metabolic substrates, indicating that PEX11 stimulates peroxisome division through a mechanism entirely independent of metabolic processes .

What experimental approaches have been used to study the function of PMP30B/PEX11B?

Multiple complementary experimental approaches have been employed to elucidate the function of PMP30B/PEX11B:

• Gene Disruption: Researchers have created PMP30 disruption vectors by replacing the coding region and flanking sequences with selectable markers like URA3 of C. boidinii . Disruption is typically confirmed by Southern analysis and Western blotting with anti-Pmp30 antibodies .

• Growth Analysis: Comparative growth rate studies in various media have been used to assess the phenotypic effects of PMP30 disruption. Wild-type and disrupted strains are grown in different carbon sources, revealing that PMP30 disruption causes varying effects depending on the substrate - from minimal effects in glucose and D-alanine media to significant growth inhibition in methanol .

• Complementation Studies: Genetic complementation experiments with PMP27 and PMP30 have demonstrated that these proteins are functional homologs, supporting hypotheses about conserved functionality across different peroxins .

• Overexpression Systems: Transfection of wild-type human fibroblasts with PEX11Bmyc plasmids, followed by immunofluorescence labeling with anti-myc antibodies or antibodies against endogenous peroxisomal membrane proteins like PEX14, has been used to visualize and quantify the effects of PEX11B on peroxisome proliferation .

• Creation of Specialized Yeast Strains: Researchers have developed strains like XLY1 (with PEX11 gene deletion and introduction of GFP/PTS1 with a GAL1 promoter) and XLY2 (a pox1 derivative of XLY1) to study PEX11 function in controlled genetic backgrounds .

How do PEX11 proteins function in the absence of peroxisomal metabolism?

Experimental evidence strongly supports that PEX11 proteins directly stimulate peroxisome division independently of metabolic function. In human mutant cell lines (PBD005) defective in peroxisomal metabolic activities, transfection with PEX11Bmyc resulted in a thirty-fold increase in peroxisome abundance compared to control cells . This finding directly challenges the previous hypothesis that PEX11 proteins primarily function in fatty acid oxidation and only indirectly affect peroxisome division.

Similarly, in yeast experiments, expression of PEX11 in specialized strains (XLY1 and XLY2) resulted in increased peroxisome numbers even when grown in media lacking fatty acids . The XLY2 strain, a pox1 derivative lacking the essential enzyme for fatty acid oxidation, still showed increased peroxisome abundance when PEX11 was expressed but not when other peroxisomal membrane proteins like PEX13 were expressed . These experiments provide compelling evidence that PEX11 stimulates peroxisome division through a mechanism entirely independent of metabolic processes.

The data suggests a model where PEX11 proteins have a primary role in the physical division process of peroxisomes, while their effects on metabolism are likely indirect consequences of altered peroxisome abundance or distribution.

What are the molecular mechanisms of PEX11-mediated peroxisome division?

The molecular mechanisms of PEX11-mediated peroxisome division involve a multi-step process that can be observed through kinetic analysis. Fluorographic studies of cells transfected with PEX11Bmyc show three distinct phases:

• Initial Phase (1.5-2 hours): Peroxisomes appear normal with PEX11B integrated into their membranes.

• Elongation Phase (4-8 hours): Peroxisomes become elongated, indicating membrane remodeling as a precursor to division.

• Division Phase (24-48 hours): Peroxisome number greatly increases, representing completed fission events .

This process occurs independently of peroxisomal metabolic functions, as demonstrated in cells lacking these functions . While the exact molecular mechanism remains to be fully elucidated, the data suggests that PEX11 likely functions directly in the membrane deformation and fission machinery required for peroxisome division.

The protein's structure, with two transmembrane segments and both N- and C-terminal regions facing the cytosol , suggests it may create membrane curvature or serve as a recruitment platform for other division factors. The dilysine motif at the C-terminus may also play a role in protein-protein interactions or membrane dynamics during the division process.

How can researchers effectively generate and purify recombinant PMP30B/PEX11B?

Based on the available research methodologies, the following approach is recommended for generating and purifying recombinant PMP30B/PEX11B:

• Gene Cloning:

  • Clone the PMP30B/PEX11B coding sequence via PCR using specific primers with appropriate restriction sites (such as NotI) to facilitate insertion into expression vectors .

• Expression Vector Construction:

  • For expression in yeast, construct a vector containing a strong inducible promoter such as the C. boidinii AOD1 promoter and terminator sequences .

  • Include a selectable marker (such as URA3) and epitope tags (such as myc) for detection and purification.

  • Verify proper orientation of the inserted fragment by physical mapping .

• Expression Systems:

  • For expression in homologous systems, transform the construct into C. boidinii strains.

  • For heterologous expression, human or mammalian cell lines with intact peroxisomal machinery provide a suitable environment.

  • Expression can be verified via Western blotting with antibodies against the protein or epitope tag .

• Purification Strategy:

  • Isolate peroxisomes through differential centrifugation and gradient purification.

  • Extract membrane proteins using appropriate detergents.

  • Utilize affinity chromatography based on the epitope tag for final purification.

What are the best methods for analyzing PMP30B/PEX11B function in experimental systems?

Several complementary methods can be employed to analyze PMP30B/PEX11B function:

• Gene Disruption Analysis:

  • Create disruption vectors by replacing the coding region with selectable markers .

  • Confirm disruption via Southern blotting and Western analysis .

  • Assess phenotypic effects through growth analysis in various media (glucose, oleate, methanol, etc.) .

• Fluorescence Microscopy for Peroxisome Morphology and Abundance:

  • Transfect cells with tagged PEX11B (e.g., PEX11Bmyc).

  • Label with antibodies against the tag or endogenous peroxisomal markers like PEX14 .

  • Quantify peroxisome number, size, and morphology at different time points.

  • Use confocal microscopy for high-resolution imaging .

• Complementation Assays:

  • Express PMP30B/PEX11B in mutant strains lacking endogenous protein.

  • Assess restoration of normal phenotype (growth rate, peroxisome number).

  • Compare with functional homologs (e.g., PMP27) to determine functional equivalence .

• Metabolic Function Analysis:

  • Measure fatty acid oxidation capacity in wild-type versus disrupted strains.

  • Utilize specialized strains (e.g., pox1 derivatives) to separate metabolic from division functions .

• Protein Topology Assessment:

  • Determine membrane orientation using protease protection assays.

  • Analyze subcellular localization via fractionation and immunoblotting .

What cellular phenotypes should be analyzed when studying PMP30B/PEX11B mutants?

When studying PMP30B/PEX11B mutants, researchers should analyze several key cellular phenotypes:

How do C. boidinii PMP30B and human PEX11 proteins compare structurally and functionally?

The structural and functional comparison between C. boidinii PMP30B and human PEX11 reveals both conservation and specialization:

• Sequence Homology:

  • Human PEX11 was identified through homology with C. boidinii PEX11, indicating significant sequence conservation .

  • Within C. boidinii, PMP30A and PMP30B variants share 93% sequence identity, with differences at only three codons .

• Structural Features:

  • Human Pex11p comprises 247 amino acids with two transmembrane segments .

  • Both proteins contain a dilysine motif at the C-terminus, important for proper localization and function .

  • Both have similar membrane topology with N- and C-terminal regions exposed to the cytosol .

• Functional Conservation:

  • PMP30 from C. boidinii and its homologs in other species (e.g., PMP27 in Saccharomyces cerevisiae) are functional equivalents as demonstrated by complementation experiments .

  • Both C. boidinii PMP30B and human PEX11 proteins are involved in peroxisome division and proliferation.

  • Human PEX11 exists in two isoforms (alpha and beta), suggesting functional specialization not observed in the yeast system .

• Metabolic Connections:

  • In C. boidinii, PMP30 disruption affects growth on specific substrates, particularly methanol .

  • In mammals, PEX11 proteins have been linked to peroxisome division independent of metabolic function .

This comparative analysis highlights the evolutionary conservation of PEX11 proteins while suggesting species-specific adaptations related to metabolic requirements and regulation mechanisms.

What are the differences between PEX11 isoforms and their implications for research?

The existence of multiple PEX11 isoforms presents important considerations for research:

• Isoform Diversity:

  • In mammals, two main isoforms exist: PEX11α and PEX11β .

  • In C. boidinii, PMP30A and PMP30B share 93% identity and are likely allelic in the polyploid strain .

• Expression Patterns:

  • Human PEX11 expression can be induced by peroxisome proliferators like clofibrate, as evidenced by the co-migration of Pex11p with the 28-kDa peroxisomal integral membrane protein (PMP28) isolated from clofibrate-treated rats .

  • Different isoforms may have tissue-specific expression patterns that must be considered when designing experiments.

• Functional Specialization:

  • Different isoforms may have specialized or overlapping functions in peroxisome division.

  • PEX11β has been directly demonstrated to cause peroxisome proliferation in human cells .

  • Experiments must carefully distinguish which isoform is being studied and avoid generalizing results across isoforms without evidence.

• Experimental Design Implications:

  • Isoform-specific antibodies, primers, and expression constructs must be used for accurate analysis.

  • When studying knockdown or knockout effects, researchers must account for potential compensatory mechanisms from other isoforms.

  • Complementation experiments should consider isoform specificity when testing functional rescue.

• Evolutionary Considerations:

  • The presence of multiple isoforms in higher eukaryotes suggests evolutionary diversification of PEX11 functions.

  • Research comparing isoform functions across species can provide insights into the evolution of peroxisome biogenesis and regulation.

What are the remaining unknowns about PMP30B/PEX11B that warrant further investigation?

Despite significant progress in understanding PMP30B/PEX11B, several key questions remain:

• Molecular Mechanism of Division:

  • The precise molecular events by which PEX11 proteins induce membrane elongation and fission remain unclear.

  • Research is needed to identify direct interaction partners during the division process.

  • The role of the dilysine motif and transmembrane domains in division mechanics requires further investigation.

• Regulation of PEX11 Activity:

  • The signaling pathways that activate or inhibit PEX11-mediated division are not fully characterized.

  • Post-translational modifications that may regulate PEX11 activity need to be identified.

  • The connection between cellular metabolic status and PEX11 function requires clarification.

• Role in Disease Processes:

  • While PEX11 is not directly responsible for the ten complementation groups of human peroxisome deficiency disorders , its potential involvement in other pathological conditions needs investigation.

  • The relationship between altered peroxisome division and metabolic diseases represents an important research direction.

• Evolutionary Adaptations:

  • The functional significance of the differences between PEX11 isoforms across species remains to be fully understood.

  • The evolutionary pressures that shaped PEX11 diversity require further study.

What novel techniques could advance PMP30B/PEX11B research?

Several emerging techniques could significantly advance PMP30B/PEX11B research:

• CRISPR-Cas9 Genome Editing:

  • Precise modification of endogenous PEX11 genes to study specific domains and motifs.

  • Creation of conditional knockout models to study temporal aspects of PEX11 function.

  • Introduction of fluorescent tags at endogenous loci for live imaging studies.

• Advanced Imaging Techniques:

  • Super-resolution microscopy to visualize peroxisome membrane dynamics during division.

  • Live-cell imaging with photoactivatable or photoswitchable fluorescent proteins to track peroxisome movement and division in real-time.

  • Correlative light and electron microscopy to connect ultrastructural changes with protein localization.

• Proteomics Approaches:

  • Proximity labeling techniques (BioID, APEX) to identify proteins that interact with PEX11 during different stages of peroxisome division.

  • Quantitative proteomics to assess changes in the peroxisomal proteome in response to PEX11 manipulation.

  • Phosphoproteomics to identify regulatory modifications of PEX11 proteins.

• In vitro Reconstitution Systems:

  • Development of membrane model systems to study PEX11-mediated membrane deformation and division in a controlled environment.

  • Cell-free expression systems to study the integration of newly synthesized PEX11 into artificial membranes.